Venous thromboembolism in psychogeriatric in-patients - A study of risk assessment, incidence, and current prophylaxis prescribing

International Psychogeriatrics

Volumn 25, Issue 6, 2013, Pages 913-917

  Liu, Xinsheng ^a   O'Rourke, Fintan ^a,b   Van Nguyen, Huong ^a,b  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

adverse events; in patients; prophylaxis; psychogeriatrics; venous thromboembolism

Indexed keywords

AGED; ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT; DEMENTIA; DEPRESSION; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; AUSTRALIA; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INCIDENCE; INPATIENTS; LENGTH OF STAY; MALE; MENTAL DISORDERS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84876732551     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610212002268     Document Type: Article

References (19)

1. Access Economics (2008). The Burden of Venous Thromboembolism in Australia. Report for the Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Barton ACT: Access Economics
2. Agnelli, G. (2004). Prevention of venous thromboembolism in surgical patients. Circulation, 110, IV4-IV12.
3. Alhenc-Gelas, M., Aiach, M. and de Moerloose, P. (2001). Venous thromboembolic disease: risk factors and laboratory investigation. Seminars in Vascular Medicine, 1, 81-87.
4. Australia and New Zealand Working Party on Management and Prevention of VTE (2005). Prevention of Venous Thromboembolism: Best Practice Guidelines for Australia and New Zealand, 3rd edn. Baulkam Hills, New South Wales: Health Education and Management Innovations.
5. Hägg, S., Jönsson, A. K. and Spigset, O. (2009). Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opinion on Drug Safety, 8, 537-547.
6. Hägg, S., Spigset, O. and Soderstrom, T. G. (2000). Association of venous thromboembolism and clozapine. Lancet, 355, 1155-1156.
7. Liperoti, R., Pedone, C., Lapane, K. L., Mor, V., Bernabei, R. and Gambassi, G. (2005). Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Archives of Internal Medicine, 165, 2677-2682.
8. Malý, R., Masopust, J. and Hosak, L. (2008). Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry and Clinical Neurosciences, 62, 3-8
9. Oger, E. (2000). Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBO Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thrombosis and Haemostasis, 83, 657-660.
10. Parker, C., Coupland, C. and Hippisley-Cox, J. (2010). Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ, 341, c4245
11. Parkin, L., Skegg, D. C., Herbison, G. P. and Paul, C. (2003). Psychotic drugs and fatal pulmonary embolism. Pharmacoepidemiology and Drug Safety, 12, 647-652.
12. Radcliffe, J. and Smith, R. (2007). Acute in-patient psychiatry: how patients spend their time on acute psychiatric wards. Psychiatric Bulletin, 31, 167-170.
13. Ray, J. G., Mamdani, M. M. and Yeo, E. L. (2002). Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thrombosis and Haemostasis, 88, 205-209.
14. Rosendaal, F. R. (1999). Risk factors for venous thrombotic disease. Thrombosis and Haemostasis, 82, 610-619.
15. Strudsholm, U., Johannessen, L., Foldager, L. and Munk-Jorgensen, P. (2005). Increased risk for pulmonary embolism in patients with bipolar disorder. Bipolar Disorders, 7, 77-81.
16. Thomassen, R., Vandenbroucke, J. P. and Rosendaal, F. R. (2001). Antipsychotic medication and venous thrombosis. British Journal of Psychiatry, 179, 63-66.
17. Vandenbroucke, J. P. et al. (1998). Factor V Leiden and fatal pulmonary embolism. Thrombosis and Haemostasis, 79, 511-516.
18. Waage, I. M. and Gedde-Dahl, A. (2003). Pulmonary embolism possibly associated with olanzapine treatment. BMJ, 37, 1384.
19. Zornberg, G. and Jick, H. (2000). Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet, 356, 1219-1223.